Chlorproguanil
Chlorproguanil[edit | edit source]
Chlorproguanil is an antimalarial drug that has been used in the treatment and prevention of malaria. It is a biguanide derivative and functions as a dihydrofolate reductase inhibitor, disrupting the folate pathway in Plasmodium parasites, which are responsible for causing malaria.
Mechanism of Action[edit | edit source]
Chlorproguanil works by inhibiting the enzyme dihydrofolate reductase (DHFR) in the malaria parasite. This enzyme is crucial for the synthesis of tetrahydrofolate, a form of folate that is necessary for the synthesis of nucleic acids and amino acids. By blocking DHFR, chlorproguanil effectively halts the replication of the parasite within the human host.
Clinical Use[edit | edit source]
Chlorproguanil has been used in combination with other antimalarial drugs to enhance its efficacy. One such combination is with dapsone, known as Lapdap. This combination was used to treat Plasmodium falciparum malaria, particularly in regions where resistance to other antimalarial drugs, such as chloroquine, is prevalent.
Resistance[edit | edit source]
Resistance to chlorproguanil can occur through mutations in the DHFR gene of the malaria parasite. These mutations reduce the binding affinity of chlorproguanil to the enzyme, thereby diminishing its effectiveness. Monitoring and managing drug resistance is a critical aspect of malaria control programs.
Safety and Side Effects[edit | edit source]
Chlorproguanil, like many antimalarial drugs, can have side effects. Common side effects include nausea, vomiting, and abdominal pain. In some cases, more severe reactions can occur, necessitating careful monitoring of patients during treatment.
Discontinuation[edit | edit source]
The use of chlorproguanil, particularly in combination with dapsone, has been discontinued in many regions due to concerns over safety and the development of resistance. Newer antimalarial therapies have been developed that offer improved efficacy and safety profiles.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
